Clinical Trial Update: Efficacy and Safety of Sivelestat in Preventing Postoperative Acute Lung Injury or Acute Respiratory Distress Syndrome After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sivelestat for prevention of postoperative acute lung injury or acute respiratory distress syndrome after cardiac surgery has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Sivelestat (sivelestat)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Cardiac Disease | Phase 3 | Status: COMPLETED